Polymorphous lymphoproliferative disorder: A clinicopathological analysis

Virchows Archiv

Volumn 456, Issue 3, 2010, Pages 269-276

  Nakamichi, Naoto ^a,b   Wada, Naoki ^a   Kohara, Masaharu ^a   Fukuhara, Shirou ^b   Sugiyama, Haruo ^c   Ogawa, Hiroyasu ^d   Hino, Masayuki ^e   Kanamaru, Akihisa ^f   Kanakura, Yuzuru ^c   Morii, Eiichi ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KINKI UNIVERSITY   (Japan)

Author keywords

B cell; Clonality; EBV; Lymphoproliferative disorder; Polymorphous; T cell

Indexed keywords

ANTHRACYCLINE; CD20 ANTIGEN; CD30 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GENE PRODUCT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE; PROTEIN BCL 2; PROTEIN BCL1; RITUXIMAB; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CLINICAL ARTICLE; CLONAL VARIATION; DRUG WITHDRAWAL; EOSINOPHIL; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; MACROPHAGE; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PLASMA CELL; POLYMERASE CHAIN REACTION; POLYMORPHOUS LYMPHOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; SOUTHERN BLOTTING; SURVIVAL RATE; T LYMPHOCYTE; VIRUS INFECTION; CELL CLONE; EPSTEIN BARR VIRUS INFECTION; IMMUNE DEFICIENCY; ISOLATION AND PURIFICATION; JAPAN; LYMPHOMA; MIDDLE AGED; PATHOLOGY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; CLONE CELLS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; JAPAN; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTES;

EID: 77949704551     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-0880-1     Document Type: Article

References (18)

1. Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon
2. DM Knowles 1999 Immunodeficiency-associated lymphoproliferative disorders Mod Pathol 12 200 217 1:STN:280:DyaK1M7mvV2iuw%3D%3D 10071343
3. Greer CE, Wheeler CM, Manos MM (1995) PCR amplification from paraffin-embedded tissues: sample preparation and the effects of fixation. In: Dieffenbach CW, Dveksler GS (eds) PCR primer: a laboratory manual. Cold Spring Harbor Laboratory, New York, pp 99-112
4. JJ van Dongen AW Langerak M Bruggemann, et al. 2003 Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936 Leukemia 17 2257 2317 10.1038/sj.leu.2403202 14671650 (Pubitemid 38072572)
5. LM Weiss ES Jaffe XF Liu, et al. 1992 Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma Blood 79 1789 1795 1:STN:280:DyaK383hs1Sruw%3D%3D 1373088
6. KJ Lewin 1997 Post-transplant lymphoproliferative disorders Pathol Oncol Res 3 177 182 10.1007/BF02899918 1:STN:280:DC%2BD1czgvVagtA%3D%3D 18470727
7. RF Little 2003 AIDS-related non-Hodgkin's lymphoma: etiology, epidemiology, and impact of highly active antiretroviral therapy Leuk Lymphoma 44 Suppl 3 S63 68 15202527
8. MA Martin-Gomez M Pena M Cabello, et al. 2006 Posttransplant lymphoproliferative disease: a series of 23 cases Transplant Proc 38 2448 2450 10.1016/j.transproceed.2006.08.050 1:STN:280:DC%2BD28nmsVCltg%3D%3D 17097963 (Pubitemid 44693706)
9. T Bando H Date M Minami, et al. 2008 First registry report: lung transplantation in Japan: The Japanese Society of Lung and Heart-Lung Transplantation Gen Thorac Cardiovasc Surg 56 17 21 10.1007/s11748-007-0161-3 18213466 (Pubitemid 351378070)
10. KW Bowman SA Richard 2003 Culture, brain death, and transplantation Prog Transplant 13 211 215 14558636
11. UNAIDS (2007) AIDS epidemic update: December 2007. Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO), Geneva
12. Y Hoshida JX Xu S Fujita, et al. 2007 Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication J Rheumatol 34 322 331 1:CAS:528:DC%2BD2sXjtFCnsbc%3D 17117491 (Pubitemid 46255749)
13. OW Kamel LM Weiss M van de Rijn, et al. 1996 Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy Am J Surg Pathol 20 1279 1287 10.1097/00000478-199610000-00015 1:STN:280:DyaK28visVGktg%3D%3D 8827036 (Pubitemid 26336854)
14. MH Ellman H Hurwitz C Thomas, et al. 1991 Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate J Rheumatol 18 1741 1743 1:STN:280:DyaK387lslWitw%3D%3D 1787499
15. E Salloum DL Cooper G Howe, et al. 1996 Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases J Clin Oncol 14 1943 1949 1:CAS:528:DyaK28XjslOrs7o%3D 8656264 (Pubitemid 26185470)
16. WH Feng JI Cohen S Fischer, et al. 2004 Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas J Natl Cancer Inst 96 1691 1702 1:CAS:528:DC%2BD2cXhtVSqsrzP 15547182 (Pubitemid 39585638)
17. E Toussirot J Roudier 2007 Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update Joint Bone Spine 74 418 426 10.1016/j.jbspin.2007.05.001 1:CAS:528:DC%2BD2sXhsVGjurzI 17625943 (Pubitemid 47595467)
18. The International Non-Hodgkin's Lymphoma Prognostic Factors Project 1993 A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 987 994 10.1056/NEJM199309303291402 (Pubitemid 23307906)